BioSpace News Archive

Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based (Polymerase Chain Reaction) DNA manufacturing for product authenticity and traceability solutions, today announced that it closed on $1.5 million in gross proceeds in secured convertible notes (the “July 2019 Notes”) by way of non-brokered private placement with an accredited investor, Dillon Hill Capital, LLC.

Employers and their employees are grappling with the rising costs of specialty drugs. High-deductible health plans (HDHPs) are one way to manage costs, but they have received some negative attention for the possible impact they have on deterring people from seeking needed medical care

Members of the media are invited to join the Honourable David Lametti, Minister of Justice and Attorney General of Canada, and Peter Schiefke, Parliamentary Secretary to the Minister of Border Security and Organized Crime Reduction, on behalf of the Honourable Bill Blair, Minister of Border Security and Organized Crime Reduction, as they make a funding announcement to the Province of Quebec to counter drug-impaired driving.

AIDS Healthcare Foundation (AHF) is calling on Gilead Sciences Inc., one of the largest manufacturers of HIV/AIDS drugs, to set up a $10 billion victim compensation fund for patients harmed after taking the drug maker’s TDF-based (tenofovir disoproxil fumarate) drugs as part of their treatment for HIV or AIDS or taken by uninfected individuals as part of the HIV prevention strategy known as pre-exposure prophylaxis or PrEP.

Today, Treasury Secretary Steven Mnuchin issued guidance to expand the scope of the preventive services safe harbor for health savings account-eligible (HSA-eligible) high-deductible health plans (HDHPs) to cover certain chronic disease services and drugs on a pre-deductible basis.

Legato Healthcare Marketing announces the acquisition of Fresh Digital Marketing, a Wisconsin-based digital agency nationally renowned for healthcare patient acquisition and engagement, and lead generation in various business-to-business industries.

8Greens, the leading health and wellness company that introduced the world’s first effervescent tablet containing eight essential greens, today announced the hiring of Eduardo Luz as CEO effective July 9, 2019.

Leuko, an MIT-born technology startup developing the first non-invasive white blood cell monitoring device, today announced it has raised $1.8 million in seed financing from Good Growth Capital, Pegasus Tech Ventures, Nina Capital, and angel investors.

Pharmaceutical Technology®, a comprehensive multimedia platform for professionals in the global pharmaceutical manufacturing drug development community, will host “Expanded Access on Commercial Packaging Strategies for Orphan, Niche, and Low-Volume Drugs,” on Tuesday, July 23, at 10 a.m. EDT.

Donations raised benefit the American Cancer Society’s Road To Recovery Program; a volunteer program providing transportation to cancer patients who otherwise might miss a potentially life-saving treatment.